title: The burden of exposure-related diffuse lung disease.
abstract: Estimating the burden of exposure-related diffuse lung disease in terms of health effects and economic burden remains challenging. Labor statistics are inadequate to define the scope of the problem, and few studies have analyzed the prevalence of exposure-related illnesses and the subsequent health care cost. Well-defined exposures, such as those associated with coal mines, asbestos mines, and stonecutting, have led to more accurate assessment of prevalence and cost. As governmental regulation of workplace exposure has increased, the prevalence of diseases such as silicosis and coal workers' pneumoconiosis has diminished. However, the health and economic effects of diseases with long latency periods, such as asbestosis and mesothelioma, continue to increase in the short term. Newer exposures, such as those related to air pollution, nylon flock, and the World Trade Center collapse, have added to these costs. As a result, estimates of cost for occupational diseases, including respiratory illnesses, exceed $26 billion annually, and the true economic burden is likely much higher.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, NYU School of Medicine, New York 10016, USA.
authors.forename: Sheryl R
authors.initials: SR
authors.lastname: Goldyn
authors.forename: Rany
authors.initials: R
authors.lastname: Condos
authors.forename: William N
authors.initials: WN
authors.lastname: Rom
mesh_terms: D000818:Animals; D017281:Cost of Illness; D033161:Government Regulation; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced / Q000191:economics* / Q000453:epidemiology; D009784:Occupational Diseases / Q000139:chemically induced / Q000191:economics* / Q000453:epidemiology; D016273:Occupational Exposure / Q000009:adverse effects / Q000191:economics*; D015995:Prevalence; D014481:United States / Q000453:epidemiology